Vivos Therapeutics, Inc. (VVOS)
1.32
+0.02
(+1.54%)
USD |
NASDAQ |
Apr 02, 16:00
1.60
+0.28
(+21.21%)
After-Hours: 20:00
Vivos Therapeutics EPS Diluted (Quarterly) : -0.4925 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Celldex Therapeutics, Inc. | -1.223 |
| Plus Therapeutics, Inc. | -1.03 |
| Atossa Therapeutics, Inc. | -1.270 |
| Abeona Therapeutics, Inc. | -0.3717 |
| Cell Source, Inc. | -0.021 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -5.40M |
| Revenue (Quarterly) | 6.783M |
| Total Expenses (Quarterly) | 12.18M |
| Enterprise Value | 21.28M |
| Gross Profit Margin (Quarterly) | 52.38% |
| Profit Margin (Quarterly) | -79.61% |
| Earnings Yield | -146.2% |
| Normalized Earnings Yield | -146.15 |